US EditionPublished • loading... • Updated
Recursion, Roche Unveil Microglia Map of Neuro Disease Targets
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized microglial immune cells that the companies plan to use toward revealing significant new targets in neurodegenerative diseases. The microglia map—which the companies have dubbed a “Google Map of the Brain” and call it a first of its kind—consists of 4…
2 Articles
2 Articles
Roche exercises Recursion deal option, Merck/Eisai's Keytruda-Lenvima combo misses endpoint, Ferring divests Rebyota, Rarity PBC gets funding, Akebia drops trial, Genentech cuts jobs
Recursion, Roche Unveil Microglia Map of Neuro Disease Targets
Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized microglial immune cells that the companies plan to use toward revealing significant new targets in neurodegenerative diseases. The microglia map—which the companies have dubbed a “Google Map of the Brain” and call it a first of its kind—consists of 4…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
